335 related articles for article (PubMed ID: 11521251)
21. Arthritis guidelines emphasize exercise.
Klippel J
Health News; 2000 Nov; 6(11):3. PubMed ID: 11100673
[No Abstract] [Full Text] [Related]
22. Defining COX-2 inhibitors.
Lipsky PE
J Rheumatol Suppl; 2000 Oct; 60():13-6. PubMed ID: 11032097
[TBL] [Abstract][Full Text] [Related]
23. [Role of cyclooxygenase-2 (COG-2) in the etiology of pain].
Nasonova VA
Ter Arkh; 2001; 73(5):56-7. PubMed ID: 11517752
[No Abstract] [Full Text] [Related]
24. Clinical experience with cyclooxygenase-2 inhibitors.
Lanas A
Rheumatology (Oxford); 2002 Apr; 41 Supp 1():16-22; discussion 35-42. PubMed ID: 12173276
[TBL] [Abstract][Full Text] [Related]
25. [COX-2 inhibitors: a new treatment in rheumatic diseases].
Puddu G; Cravero E
Clin Ter; 2003; 154(1):39-43. PubMed ID: 12854282
[TBL] [Abstract][Full Text] [Related]
26. [Tolerable pain therapy in rheumatism saves long-term costs. Despite this most COX-2 candidates receive conventional NSAID therapy].
MMW Fortschr Med; 2003 Jul; 145(29-30):61. PubMed ID: 12958786
[No Abstract] [Full Text] [Related]
27. [Present status and future trends in the development of therapeutic agents for collagen diseases].
Kawai S
Nihon Naika Gakkai Zasshi; 2001 Nov; 90(11):2317-24. PubMed ID: 11769536
[No Abstract] [Full Text] [Related]
28. Are selective COX 2 inhibitors superior to traditional non steroidal anti-inflammatory drugs?
Jüni P; Rutjes AW; Dieppe PA
BMJ; 2002 Jun; 324(7349):1287-8. PubMed ID: 12039807
[No Abstract] [Full Text] [Related]
29. Longer use of COX-2-specific inhibitors compared to nonspecific nonsteroidal antiinflammatory drugs: a longitudinal study of 3639 patients in community practice.
Wolfe F; Michaud K; Burke TA; Zhao SZ
J Rheumatol; 2004 Feb; 31(2):355-8. PubMed ID: 14760808
[TBL] [Abstract][Full Text] [Related]
30. COX-2 inhibitors.
Crowther CL
Lippincotts Prim Care Pract; 1999; 3(4):394-6. PubMed ID: 10624270
[No Abstract] [Full Text] [Related]
31. COX-1-sparing NSAIDs--is the enthusiasm justified?
Peterson WL; Cryer B
JAMA; 1999 Nov; 282(20):1961-3. PubMed ID: 10580464
[No Abstract] [Full Text] [Related]
32. [Selective COX-2 inhibitors for therapy of rheumatoid arthritis].
Sano H
Nihon Rinsho; 2005 Jan; 63 Suppl 1():477-87. PubMed ID: 15799403
[No Abstract] [Full Text] [Related]
33. Clinical implications of selective cyclooxygenase-2 inhibition.
Emery P
Scand J Rheumatol Suppl; 1996; 102():23-8. PubMed ID: 8628978
[TBL] [Abstract][Full Text] [Related]
34. Controversies in COX-2 inhibitor therapy: closing remarks.
Abramson SB; Furst DE; Hochberg MC; Patrono C
Clin Exp Rheumatol; 2001; 19(6 Suppl 25):S77-80. PubMed ID: 11695257
[No Abstract] [Full Text] [Related]
35. Arthritis in older adults.
Luggen AS
Geriatr Nurs; 2001; 22(3):118. PubMed ID: 11410760
[No Abstract] [Full Text] [Related]
36. [Specific COX-2 inhibitors. Also effective in arthritis?].
Einecke D
MMW Fortschr Med; 2000 Jan; 142(3):10. PubMed ID: 10726454
[No Abstract] [Full Text] [Related]
37. [No loss of effectiveness with rofecoxib. Long-term control of rheumatoid pain].
Einecke D
MMW Fortschr Med; 2002 Nov; 144(46):68. PubMed ID: 12534087
[No Abstract] [Full Text] [Related]
38. [NSAIDs for therapy of rheumatoid arthritis. Introduction].
Takasaki Y
Nihon Rinsho; 2005 Jan; 63 Suppl 1():473-6. PubMed ID: 15799402
[No Abstract] [Full Text] [Related]
39. [Current status of COX II inhibitors in therapy of rheumatoid arthritis in comparison with conventional non-steroidal anti-inflammatory agents. Attempt at an evaluation with regard to evidence-based medicine].
Krüger K
Z Rheumatol; 2001 Dec; 60(6):481-4. PubMed ID: 11826746
[No Abstract] [Full Text] [Related]
40. COX-1, COX-2: so what?
Emery P
Scand J Rheumatol; 1999; 28(1):6-9. PubMed ID: 10092158
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
